BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 32903337)

  • 1. Promoter Hypomethylation and miR-145-5p Downregulation- Mediated HDAC11 Overexpression Promotes Sorafenib Resistance and Metastasis of Hepatocellular Carcinoma Cells.
    Wang W; Ding B; Lou W; Lin S
    Front Cell Dev Biol; 2020; 8():724. PubMed ID: 32903337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long noncoding RNA SNHG16 induces sorafenib resistance in hepatocellular carcinoma cells through sponging miR-140-5p.
    Ye J; Zhang R; Du X; Chai W; Zhou Q
    Onco Targets Ther; 2019; 12():415-422. PubMed ID: 30655679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ago-RIP Sequencing Identifies New MicroRNA-449a-5p Target Genes Increasing Sorafenib Efficacy in Hepatocellular Carcinoma.
    Reinkens T; Stalke A; Huge N; Vajen B; Eilers M; Schäffer V; Dittrich-Breiholz O; Schlegelberger B; Illig T; Skawran B
    J Cancer; 2022; 13(1):62-75. PubMed ID: 34976171
    [No Abstract]   [Full Text] [Related]  

  • 4. Histone Deacetylase Expressions in Hepatocellular Carcinoma and Functional Effects of Histone Deacetylase Inhibitors on Liver Cancer Cells In Vitro.
    Freese K; Seitz T; Dietrich P; Lee SML; Thasler WE; Bosserhoff A; Hellerbrand C
    Cancers (Basel); 2019 Oct; 11(10):. PubMed ID: 31635225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endoplasmic reticulum stress promotes sorafenib resistance via miR-188-5p/hnRNPA2B1-mediated upregulation of PKM2 in hepatocellular carcinoma.
    Zhou B; Lu D; Wang A; Cui J; Zhang L; Li J; Fan L; Wei W; Liu J; Sun G
    Mol Ther Nucleic Acids; 2021 Dec; 26():1051-1065. PubMed ID: 34786210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of sorafenib on lung metastasis in rats with hepatocellular carcinoma: the role of microRNAs.
    Shi Y; Huang A
    Tumour Biol; 2015 Nov; 36(11):8455-63. PubMed ID: 26026584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A microRNA-7/growth arrest specific 6/TYRO3 axis regulates the growth and invasiveness of sorafenib-resistant cells in human hepatocellular carcinoma.
    Kabir TD; Ganda C; Brown RM; Beveridge DJ; Richardson KL; Chaturvedi V; Candy P; Epis M; Wintle L; Kalinowski F; Kopp C; Stuart LM; Yeoh GC; George J; Leedman PJ
    Hepatology; 2018 Jan; 67(1):216-231. PubMed ID: 28833396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LINC00540 promotes sorafenib resistance and functions as a ceRNA for miR-4677-3p to regulate AKR1C2 in hepatocellular carcinoma.
    Xu K; Wang X; Hu S; Tang J; Liu S; Chen H; Zhang X; Dai P
    Heliyon; 2024 Mar; 10(5):e27322. PubMed ID: 38463802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PU.1 Is Identified as a Novel Metastasis Suppressor in Hepatocellular Carcinoma Regulating the miR-615-5p/IGF2 Axis.
    Song LJ; Zhang WJ; Chang ZW; Pan YF; Zong H; Fan QX; Wang LX
    Asian Pac J Cancer Prev; 2015; 16(9):3667-71. PubMed ID: 25987019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA SNHG7 accelerates the proliferation, migration and invasion of hepatocellular carcinoma cells via regulating miR-122-5p and RPL4.
    Yang X; Sun L; Wang L; Yao B; Mo H; Yang W
    Biomed Pharmacother; 2019 Oct; 118():109386. PubMed ID: 31545291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-1226-3p Promotes Sorafenib Sensitivity of Hepatocellular Carcinoma via Downregulation of DUSP4 Expression.
    Chen X; Tan W; Li W; Li W; Zhu S; Zhong J; Shang C; Chen Y
    J Cancer; 2019; 10(12):2745-2753. PubMed ID: 31258782
    [No Abstract]   [Full Text] [Related]  

  • 12. ING4 suppresses hepatocellular carcinoma via a NF-κB/miR-155/FOXO3a signaling axis.
    Qian F; Hu Q; Tian Y; Wu J; Li D; Tao M; Qin L; Shen B; Xie Y
    Int J Biol Sci; 2019; 15(2):369-385. PubMed ID: 30745827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA NEAT1 modulates sorafenib resistance in hepatocellular carcinoma through regulating the miR-149-5p/AKT1 axis.
    Niu Y; Tang G; Wu X; Wu C
    Saudi J Gastroenterol; 2020 May; 26(4):194-203. PubMed ID: 32461380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TGFβ1- miR-140-5p axis mediated up-regulation of Flap Endonuclease 1 promotes epithelial-mesenchymal transition in hepatocellular carcinoma.
    Li C; Zhou D; Hong H; Yang S; Zhang L; Li S; Hu P; Ren H; Mei Z; Tang H
    Aging (Albany NY); 2019 Aug; 11(15):5593-5612. PubMed ID: 31402791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydroxychloroquine (HCQ) Modulates Autophagy and Oxidative DNA Damage Stress in Hepatocellular Carcinoma to Overcome Sorafenib Resistance via TLR9/SOD1/hsa-miR-30a-5p/Beclin-1 Axis.
    Chen MY; Yadav VK; Chu YC; Ong JR; Huang TY; Lee KF; Lee KH; Yeh CT; Lee WH
    Cancers (Basel); 2021 Jun; 13(13):. PubMed ID: 34203465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Galectin-1 promotes hepatocellular carcinoma and the combined therapeutic effect of OTX008 galectin-1 inhibitor and sorafenib in tumor cells.
    Leung Z; Ko FCF; Tey SK; Kwong EML; Mao X; Liu BHM; Ma APY; Fung YME; Che CM; Wong DKH; Lai CL; Ng IO; Yam JWP
    J Exp Clin Cancer Res; 2019 Oct; 38(1):423. PubMed ID: 31640796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KDM4B-mediated epigenetic silencing of miRNA-615-5p augments RAB24 to facilitate malignancy of hepatoma cells.
    Chen Z; Wang X; Liu R; Chen L; Yi J; Qi B; Shuang Z; Liu M; Li X; Li S; Tang H
    Oncotarget; 2017 Mar; 8(11):17712-17725. PubMed ID: 27487123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A c-Myc/miR-17-5p feedback loop regulates metastasis and invasion of hepatocellular carcinoma.
    Liu D; Dong L; Liu Y; Wen D; Gao D; Sun H; Fan J; Wu W
    Tumour Biol; 2016 Apr; 37(4):5039-47. PubMed ID: 26546431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FAM225A promotes sorafenib resistance in hepatocarcinoma cells through modulating miR-130a-5p-CCNG1 interaction network.
    Liu YT; Liu GQ; Huang JM
    Biosci Rep; 2020 Nov; 40(12):. PubMed ID: 33245102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of miR-16-5p in the proliferation and metastasis of hepatocellular carcinoma.
    Cheng B; Ding F; Huang CY; Xiao H; Fei FY; Li J
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):137-145. PubMed ID: 30657555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.